يحاول ذهب - حر

Probe Ringer's lactate maker: Health dept to DCGI

December 04, 2024

|

The New Indian Express Bengaluru

The Karnataka Government has written to the Drugs Controller General of India (DCGI), requesting to investigate and initiate action against a West Bengal-based pharmaceutical company, the manufacturer of Ringer's lactate (RL) solution, amid suspicion that the recent maternal deaths in Ballari might be due to the use of alleged substandard solution from the company.

- EXPRESS NEWS SERVICE @ Bengaluru

In a letter dated December 3, the Principal Secretary of the Health and Family Welfare Department, Harsh Gupta, drew the attention of the DCGI towards the supply of several batches of "Compound Sodium Lactate Injection I.P (Ringer's lactate 1.P)" by West Bengal-based Paschim Banga Pharmaceuticals to the Karnataka State Medical Supplies Corporation Limited (KSMSCL - Govt Supply) for consumption in government hospitals through district drug warehouses.

المزيد من القصص من The New Indian Express Bengaluru

The New Indian Express Bengaluru

India, Germany intent on def ties

Two countries announce road map for joint military production, naval exercises & training

time to read

2 mins

January 13, 2026

The New Indian Express Bengaluru

The New Indian Express Bengaluru

'HINDI CINEMA HAS LEARNT THE WRONG LESSONS FROM HOLLYWOOD'

Vivaan Shah, who delivered an impressive performance in a brief role in Ikkis, talks about how Sriram Raghavan is an inclusive filmmaker, what he despises about current mainstream cinema, and more

time to read

3 mins

January 13, 2026

The New Indian Express Bengaluru

Trade talks back, India on Pax Silica: Gor

SIGNALLING an early effort to stabilise India-US ties that have come under strain amid tariff disputes and market jitters, Washington's new ambassador to New Delhi, Sergio Gor, on Monday said the two sides will take up the outstanding trade issues during a call on Tuesday.

time to read

1 min

January 13, 2026

The New Indian Express Bengaluru

The New Indian Express Bengaluru

PSLV’s third-stage fails for second time in a row

Even as AI-driven deals lifted revenues for India’s top IT firms in the December quarter, new labour codes weighed heavily on profits

time to read

1 min

January 13, 2026

The New Indian Express Bengaluru

'Quality is not linked to price'

DR Cyriac Abby Philips, clinician-scientist and president of the Mission for Ethics and Science in Health (MESH) explains the motivation behind the study, its surprising findings, and what this mean for patients and doctors alike.

time to read

1 min

January 13, 2026

The New Indian Express Bengaluru

The New Indian Express Bengaluru

'HINDI CINEMA HAS LEARNT THE WRONG LESSONS FROM HOLLYWOOD'

Vivaan Shah, who delivered an impressive performance in a brief role in Ikkis, talks about how Sriram Raghavan is an inclusive filmmaker, what he despises about current mainstream cinema, and more

time to read

3 mins

January 13, 2026

The New Indian Express Bengaluru

'Quality is not linked to price'

DR Cyriac Abby Philips, clinician-scientist and president of the Mission for Ethics and Science in Health (MESH) explains the motivation behind the study, its surprising findings, and what this mean for patients and doctors alike.

time to read

1 min

January 13, 2026

The New Indian Express Bengaluru

The New Indian Express Bengaluru

2 die in Indore due to water contamination, 9 in hospital

TWO more deaths have reportedly happened in the country’s cleanest city, Indore, due to contaminated water triggering a diarrhoea outbreak, taking the toll to 23 to date.

time to read

1 mins

January 13, 2026

The New Indian Express Bengaluru

SC to examine validity of lifelong immunity to CEC and poll commissioners

THE Supreme Court on Monday decided to examine the validity of the Parliament-enacted law giving lifelong immunity from legal proceedings to Chief Election Commissioner (CEC) and Election Commissioners (ECs).

time to read

1 min

January 13, 2026

The New Indian Express Bengaluru

INDIA FACES 2nd HIGHEST ECONOMIC BURDEN DUE TO DIABETES

NDIA faces the second highest economic burden of $11.4 trillion due to diabetes —the US bears the highest costs at $16.5 trillion, and China the third at $11 trillion, a new study has estimated.

time to read

2 mins

January 13, 2026

Listen

Translate

Share

-
+

Change font size